Company Listing
IFM Therapeutics

IFM Therapeutics is an early-stage biopharmaceutical company developing a portfolio of first-in-class small molecules modulating the innate immune system. These are intended either to enhance innate immune responses for treating cancer, or to dampen certain responses that drive inflammatory diseases.

BACK
Location
Cambridge, Massachusetts
CEO
Gary Glick
Abingworth Partner
Vincent Miles
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

IFM Therapeutics is an early-stage biopharmaceutical company developing a portfolio of first-in-class small molecules modulating the innate immune system. These are intended either to enhance innate immune responses for treating cancer, or to dampen certain responses that drive inflammatory diseases.

Location
Cambridge, Massachusetts
CEO
Gary Glick
Abingworth Partner
Vincent Miles
Website Address
BACK
 
Copyright Abingworth 2017